Posted on
Share on Facebook
Share on Twitter
Share on LinkedIn

Watchdog group Public Citizen urged U.S. regulators on Tuesday not to approve Arena Pharmaceuticals Inc's experimental diet pill lorcaserin, citing concerns it could increase patients' risk of heart valve damage.

Click here to read more.